🇺🇸 FDA
Patent

US 9499494

Pyrimidine-2,4,6-triones for use in the treatment of amyotrophic lateral sclerosis

granted A61PA61P25/00A61P25/28

Quick answer

US patent 9499494 (Pyrimidine-2,4,6-triones for use in the treatment of amyotrophic lateral sclerosis) held by Northwestern University expires Mon Nov 17 2036 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Northwestern University
Grant date
Tue Nov 22 2016 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Nov 17 2036 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
23
CPC classes
A61P, A61P25/00, A61P25/28